VCI Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCI Wealth Management's DGX Position: Q3 2026 in Review
VCI Wealth Management sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 11,636 shares — an estimated $2.47M sold.
VCI Wealth Management first reported a position in DGX in Q4 2025 and held it in 3 quarters. The position peaked at $2.47M in Q2 2026. 1,139 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- VCI Wealth Management reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
- VCI Wealth Management sold 11,636 Quest Diagnostics shares in Q3 2026, an estimated $2.47M.
- VCI Wealth Management first reported a position in Quest Diagnostics in Q4 2025 and held it in 3 quarters.
- VCI Wealth Management's Quest Diagnostics position peaked at $2.47M in Q2 2026.
- 1,139 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on VCI Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.